Tezacaftor for the treatment of cystic fibrosis.

Abstract excerpt

INTRODUCTION: Cystic fibrosis (CF) is the most common, life-limiting autosomal recessive disease in Caucasians, and is caused by defects in production of the CFTR ion channel. Until recently, there were no available treatments targeting the disease-causing defects in CFTR but newly developed CFTR modulators are changing the course of disease in CF. The newest modulator, tezacaftor, is a CFTR corrector that was...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aminophenols
• Share to Aminopyridines
• Share to Benzodioxoles